Soleno Therapeutics Announces Presentation of DCCR Data at the 11th International Prader-Willi Syndrome Organisation Conference
11.07.2022 - REDWOOD CITY, Calif., July 11, 2022 (GLOBE NEWSWIRE) - Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced presentations at ... Seite 1
Siri Bolding Adam Pittman Jenniferl Miller Casimir Inc Foundation For Prader Willi Research University Of Florida School Medicine
Source: wallstreet-online.de